Oct 23, 4:13 PM ET
Macy's, Inc. said director Paul C. Varga will resign from its Board effective December 11, 2026, citing no disagreement with the company. Deirdre P. Connelly will succeed him as Lead Independent Director effective December 12, 2026, and the board will have nine directors after his departure.
- Paul C. Varga, a director since 2012 and Lead Independent Director since 2021, will resign effective December 11, 2026
- Deirdre P. Connelly elected Lead Independent Director effective December 12, 2026
- Board size fixed at nine directors effective December 11, 2026
- Company says the resignation was not due to any disagreement with the company, board or management
Read the filing on SEC.gov ↗
Sep 10, 6:57 AM ET
Macy's reported second-quarter 2026 results for the 13 weeks ended August 1, 2026, with net sales up 1.1% to $4.9 billion and GAAP diluted EPS of $0.62, up from $0.31 a year earlier. The company raised its full-year 2026 guidance, including adjusted diluted EPS of $2.15 to $2.35, up from $2.00 to $2.20, and the quarter included a $0.23 per share net tariff refund benefit.
- Net sales rose 1.1% to $4.9 billion; comparable sales rose 2.7%, and Bloomingdale's comparable sales rose 11.3%.
- GAAP diluted EPS was $0.62 versus $0.31; adjusted diluted EPS was $0.63 versus $0.35, including a $0.23 net tariff refund benefit.
- Full-year 2026 guidance now calls for net sales of $21.675 billion to $21.825 billion and comparable sales growth of 1.0% to 1.5%.
- The board declared a quarterly dividend of 19.15 cents per share, payable October 1, 2026, to holders of record on September 15, 2026.
Read the filing on SEC.gov ↗
Jun 3, 6:59 AM ET
Macy's reported first-quarter 2026 results for the 13 weeks ended May 2, 2026, with comparable sales up 3.0% and GAAP diluted EPS of $0.23, up from $0.13 a year earlier. The company raised its full-year 2026 guidance for net sales, comparable sales and adjusted diluted EPS, with adjusted diluted EPS now expected at $2.00 to $2.20 versus $1.90 to $2.10 previously. Shareholders gain from higher sales and profit measures, though gross margin declined and adjusted EBITDA fell year over year.
- Comparable sales rose 3.0%, with Bloomingdale's up 10.2%, Macy's up 1.6% and Bluemercury up 6.4%.
- Net sales rose 1.8% to $4.7 billion; adjusted diluted EPS was $0.13 versus $0.11, and GAAP diluted EPS was $0.23 versus $0.13.
- Gross margin rate fell 30 basis points to 38.9%, and adjusted EBITDA was $290 million versus $304 million.
- Full-year 2026 adjusted diluted EPS guidance rose to $2.00 to $2.20 from $1.90 to $2.10; the board declared a 19.15 cent quarterly dividend payable July 1, 2026.
Read the filing on SEC.gov ↗
May 18, 4:52 PM ET
At its May 15, 2026 virtual annual meeting, Macy's shareholders approved an amendment and restatement of the 2024 Equity and Incentive Compensation Plan, which the board had approved on March 26, 2026. Shareholders also elected all 10 director nominees, ratified KPMG LLP as auditor for the fiscal year ending January 30, 2027, and approved the advisory vote on executive compensation. The filing reports approvals for every item, though several votes drew substantial opposition.
- Equity plan amendment approved on May 15, 2026: 184,361,310 for, 16,423,087 against, 431,131 abstentions.
- Deirdre P. Connelly received the lowest director support: 156,001,716 for and 44,469,777 against.
- KPMG LLP ratified as independent auditor: 214,069,467 for and 10,047,654 against.
- Executive compensation advisory vote approved: 157,691,659 for and 43,025,428 against.
Read the filing on SEC.gov ↗
Briefs are written by AI from the filing text (each brief's own page names the model) and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the model's reading of the filing for shareholders, not a price forecast. Not investment advice.